Education
About Us
Working with TipRanks
Follow Us
Carmell Therapeutics Corporation (CTCX)
NASDAQ:CTCX
CTCX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.17 - $3.00
Previous Close$0.44
Volume482.57K
Average Volume (3M)232.88K
Market Cap
$9.64M
Enterprise ValueN/A
Total Cash (Recent Filing)$892.16K
Total Debt (Recent Filing)$1.54M
Price to Earnings (P/E)―
Beta1.66
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.56
Shares Outstanding30,119,843
10 Day Avg. Volume179,341
30 Day Avg. Volume232,880
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)137.49
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Carmell Therapeutics News
PremiumCompany Announcements
Carmell Therapeutics Announces Leadership Transition and New CEO
PremiumCompany Announcements
Carmell Therapeutics Unveils Innovative Skincare Breakthroughs---
Ownership Overview
16.39% Insiders
0.86% Mutual Funds
2.01% Other Institutional Investors
80.09% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
CTCX FAQ
What was Carmell Therapeutics Corporation’s price range in the past 12 months?
Carmell Therapeutics Corporation lowest stock price was $0.17 and its highest was $3.00 in the past 12 months.
What is Carmell Therapeutics Corporation’s market cap?
Carmell Therapeutics Corporation’s market cap is $9.64M.
When is Carmell Therapeutics Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Carmell Therapeutics Corporation’s earnings last quarter?
Currently, no data Available
Is Carmell Therapeutics Corporation overvalued?
According to Wall Street analysts Carmell Therapeutics Corporation’s price is currently Overvalued.
Does Carmell Therapeutics Corporation pay dividends?
Carmell Therapeutics Corporation does not currently pay dividends.
What is Carmell Therapeutics Corporation’s EPS estimate?
Carmell Therapeutics Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Carmell Therapeutics Corporation have?
Carmell Therapeutics Corporation has 30,119,843 shares outstanding.
What happened to Carmell Therapeutics Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Carmell Therapeutics Corporation?
Currently, no hedge funds are holding shares in CTCX
---
Company Description
Carmell Therapeutics Corporation
Alpha Healthcare Acquisition Corp III is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
Technical Analysis
Orasure Technologies
―
Fate Therapeutics
―
MiMedx Group
―
CryoPort
―
Brainstorm Cell Therapeutics
―
---